Federica Marchesin
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Beyond the limits of conventional 'endpoint' ELISA and rescuing the signal with lag k-ELISA.
Journal: Journal of virological methods
Published: April 01, 2025
SARS-CoV-2 antibody responses associate with sex, age and disease severity in previously uninfected people admitted to hospital with COVID-19: An ISARIC4C prospective study.
Journal: Frontiers in immunology
Published: January 17, 2023
Long-term persistence of natural anti-SARS-CoV-2 antibodies and mild impact of SARS-CoV-2 infection in CML patients: results from a seroprevalence study.
Journal: Leukemia & lymphoma
Published: January 24, 2022
Durable humoral responses after the second anti-SARS-CoV-2 vaccine dose in chronic myeloid leukaemia patients on tyrosine kinase inhibitors.
Journal: British journal of haematology
Published: November 19, 2021
Detection and quantification of antibody to SARS CoV 2 receptor binding domain provides enhanced sensitivity, specificity and utility.
Journal: Journal of virological methods
Published: November 03, 2021
Simple, sensitive, specific self-sampling assay secures SARS-CoV-2 antibody signals in sero-prevalence and post-vaccine studies.
Journal: Scientific reports
Published: June 17, 2021
SARS-CoV-2 lateral flow assays for possible use in national covid-19 seroprevalence surveys (React 2): diagnostic accuracy study.
Journal: BMJ (Clinical research ed.)
Published: March 03, 2021
Longevity of SARS-CoV-2 immune responses in hemodialysis patients and protection against reinfection.
Journal: Kidney international
Published: January 27, 2021
The Association Between Antibody Response to Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Post-COVID-19 Syndrome in Healthcare Workers.
Journal: The Journal of infectious diseases
Published: December 27, 2020
Showing 1-10 of 10
Last Updated: 09/26/2026